Use of Interferon-Gamma Release Assays in a Health Care Worker Screening Program: Experience from a Tertiary Care Centre in the United States | Zendy

Manish Joshi | Zendy; Thomas P. Monson | Zendy; Gail L. Woods | Zendy

Open Access

Use of Interferon-Gamma Release Assays in a Health Care Worker Screening Program: Experience from a Tertiary Care Centre in the United States

Author(s) -

Manish Joshi,

Thomas P. Monson,

Gail L. Woods

Publication year - 2012

Publication title -

canadian respiratory journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.675

H-Index - 53

eISSN - 1916-7245

pISSN - 1198-2241

DOI - 10.1155/2012/576324

Subject(s) - medicine , tuberculin , interferon gamma release assay , health care , tuberculosis , tertiary care , interferon γ , mycobacterium tuberculosis , test (biology) , family medicine , interferon gamma , latent tuberculosis , pathology , paleontology , cytokine , economics , biology , economic growth

Interferon-gamma release assays including the QuantiFERON-TB Gold In-Tube test (QFT-GIT [Cellestis Ltd, Australia]) may be used in place of the tuberculin skin test (TST) in surveillance programs for Mycobacterium tuberculosis infection control. However, data on performance and practicality of the QFT-GIT in such programs for health care workers (HCWs) are limited.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research